MOH-IL-2020-0080-V280

Type IB variation for application MOH-IL-2020-0080. Type IB variation: Formulation Change for Fabrizyme-β — major revision

Variation Number
MOH-IL-2020-0080-V280
Type
Type IB
Application
MOH-IL-2020-0080
Change
CHG-2021-0280
Status
In Progress
Fee
€2,473
Submitted
—
Approved
—
Description

Type IB variation: Formulation Change for Fabrizyme-β — major revision